Geneva Advisors’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q3
Sell
-2,963
Closed -$242K 658
2015
Q2
$242K Buy
+2,963
New +$242K ﹤0.01% 566